Homepage Bottom Left
-
Biomarin’s gene therapy for hemophilia A to be called Roctavian
Montreal, May 14, 2020 – Biomarin announced on May 11 its gene therapy currently awaiting approval by the U.S. Food and Drug Administration will be...
-
Interview with Nurul Islam, president of the Hemophilia Society of Bangladesh
Interview with Nurul Islam, president of the Hemophilia Society of Bangladesh, about the role twinning played on their success in getting their government to fund...
-
Message from CHS President, Paul Wilton
With every challenge comes opportunity. Imagine if we had set out to make all the changes the world has made in the past month. Transitioning...
-
New CHS social media campaign for women and bleeding disorders
In 2019, the Canadian Hemophilia Society was proud to have tested a new social media campaign aimed at raising awareness of women and bleeding disorders...
-
Patient-reported outcomes via MyCBDR and PROBE: essential to patient advocacy
Montreal, April 17, 2020 – In recent years, the creation of electronic tools that allow people with hemophilia (PwH) to report their health outcomes to...